Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals Announces Appointment of Industry Veteran David Madden as Chairman of the Board
Published in Drug Law Weekly, July 21st, 2009
Dicerna Pharmaceuticals, Inc., a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and dicer substrate RNA (DsiRNA) molecules, announced the appointment of pharmaceutical industry veteran David M. Madden as Dicerna's independent chairman of the Board. The appointment was confirmed during the Company's most recent Board of Directors meeting and is effective immediately. Douglas M. Fambrough, Ph.D., general partner with Oxford Biosciences Partners, and previous chairman, remains on the now six-person Dicerna Board.
"I'm very pleased to welcome Mr. Madden as an independent director and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-07-21)
More Articles from Drug Law Weekly
- Allergies
Study data from T.M. Cook et al provide new insights into allergies - American College of Physicians
Internists support broad goals of House 'tri-committee' proposed health-reform legislation - AmWINS Group Benefits
Six Ways to Fix the American Healthcare System - BioTime, Inc.
BioTime, Inc. Adds New Members to Its Board of Directors - Digital Angel
Digital Angel's Destron Fearing Division Signs Contract Extension with Schering-Plough's Animal Health Unit - Drug Abuse
Drug Crimes in Canada Cause Continuing Problems for Small Communities - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
